These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14565477)

  • 41. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides.
    Arima H; Sakamoto T; Aramaki Y; Ishidate K; Tsuchiya S
    J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of p21(WAF1/CIP1) and estrogen receptor alpha in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA).
    Jepsen JS; Pfundheller HM; Lykkesfeldt AE
    Oligonucleotides; 2004; 14(2):147-56. PubMed ID: 15294077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Technology evaluation: ISIS-3521.
    Li K; Zhang J; Sirois P; Hu Y
    Curr Opin Mol Ther; 1999 Jun; 1(3):393-8. PubMed ID: 11713804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TPA-enhanced motility and invasion in a highly metastatic variant (L-10) of human rectal adenocarcinoma cell line RCM-1: selective role of PKC-alpha and its inhibition by a combination of PDBu-induced PKC downregulation and antisense oligonucleotides treatment.
    Shimao Y; Nabeshima K; Inoue T; Koono M
    Clin Exp Metastasis; 1999 Jun; 17(4):351-60. PubMed ID: 10545022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition.
    Saijo Y; Uchiyama B; Abe T; Satoh K; Nukiwa T
    Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spinal distribution and metabolism of 2'-O-(2-methoxyethyl)-modified oligonucleotides after intrathecal administration in rats.
    Butler M; Hayes CS; Chappell A; Murray SF; Yaksh TL; Hua XY
    Neuroscience; 2005; 131(3):705-15. PubMed ID: 15730875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of the alpha isoenzyme of protein kinase C in the growth inhibition induced by phorbol esters in MH1C1 hepatoma cells.
    Perletti GP; Smeraldi C; Porro D; Piccinini F
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1589-94. PubMed ID: 7811240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein kinase C as a target for cancer therapy.
    Glazer RI
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):235-8. PubMed ID: 9212917
    [No Abstract]   [Full Text] [Related]  

  • 49. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.
    Wahlestedt C; Salmi P; Good L; Kela J; Johnsson T; Hökfelt T; Broberger C; Porreca F; Lai J; Ren K; Ossipov M; Koshkin A; Jakobsen N; Skouv J; Oerum H; Jacobsen MH; Wengel J
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5633-8. PubMed ID: 10805816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides.
    Masanek U; Stammler G; Volm M
    J Exp Ther Oncol; 2002; 2(1):37-41. PubMed ID: 12415618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
    Chen CC; Wang JK; Lin SB
    J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
    Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS
    Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
    Yazaki T; Ahmad S; Chahlavi A; Zylber-Katz E; Dean NM; Rabkin SD; Martuza RL; Glazer RI
    Mol Pharmacol; 1996 Aug; 50(2):236-42. PubMed ID: 8700129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
    Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
    Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis is induced in glioma cells by antisense oligonucleotides to protein kinase C alpha and is enhanced by cycloheximide.
    Dooley NP; Baltuch GH; Groome N; Villemure JG; Yong VW
    Neuroreport; 1998 Jun; 9(8):1727-33. PubMed ID: 9665591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
    Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
    J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
    Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ
    Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antisense oligodeoxynucleotide to PKC-delta blocks alpha 1-adrenergic activation of Na-K-2Cl cotransport.
    Liedtke CM; Cole T
    Am J Physiol; 1997 Nov; 273(5):C1632-40. PubMed ID: 9374649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase.
    Monia BP; Johnston JF; Geiger T; Muller M; Fabbro D
    Nat Med; 1996 Jun; 2(6):668-75. PubMed ID: 8640558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Definition by specific antisense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes.
    Lee YS; Dlugosz AA; McKay R; Dean NM; Yuspa SH
    Mol Carcinog; 1997 Jan; 18(1):44-53. PubMed ID: 9022812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.